Why more women get Alzheimer’s disease

Credit: Unsplash+.

Recent studies from the University of Chicago are shining a new light on Alzheimer’s disease, offering hope for future treatments.

These studies dive deep into how Alzheimer’s symptoms develop differently between males and females, focusing particularly on the roles of estrogen and the gut microbiome.

Alzheimer’s disease, known for its formation of brain-clogging amyloid plaques and triggering of inflammation, might have a closer relationship with our gut bacteria than previously thought.

In new research led by Dr. Sangram Sisodia, an experiment with mouse models of Alzheimer’s revealed that antibiotics could reduce amyloid plaque formation and inflammation in male mice, but not in females.

This led to a fascinating discovery: the gut microbiome, or the community of bacteria living in our digestive system, plays a significant role in the development of Alzheimer’s symptoms.

Altering the gut microbiome by transplanting fecal matter from untreated mice into antibiotic-treated ones reversed the benefits, hinting at the microbiome’s direct impact on the disease.

A Closer Look at Gender Differences

Further investigation into these sex-specific responses uncovered intriguing insights. A drug derived from brown seaweed, called GV-971, showed promise in reducing amyloid deposits and inflammation in Alzheimer’s mouse models, but again, only in males.

This led researchers to find significant changes in the gut bacteria of treated male mice, with certain bacterial species standing out. These findings, replicated across different research labs, suggest a strong link between the microbiome and Alzheimer’s, influenced by the sex of the individual.

Estrogen’s Impact on Alzheimer’s

Another layer of complexity was added by exploring estrogen’s role. Estrogen, the primary female hormone, was suspected to influence Alzheimer’s development.

Research showed that increasing estrogen levels in mice through antibiotic treatment or hormonal manipulation led to changes in amyloid deposition and inflammation.

Remarkably, removing the ovaries of female mice, which stops estrogen production, reduced Alzheimer’s-like symptoms. This suggests that estrogen significantly influences the disease’s progression, potentially through its effect on the gut microbiome.

Challenging Conventional Wisdom

These findings challenge the long-held belief that hormone replacement therapy, which increases estrogen levels in postmenopausal women, could help prevent cognitive decline.

Instead, the research suggests that estrogen replacement might not be beneficial and could even increase the risk of Alzheimer’s. This revelation calls for a reevaluation of hormone replacement therapy’s role in managing menopause symptoms and preventing dementia.

Future Directions

Understanding the intricate relationship between estrogen levels, the gut microbiome, and Alzheimer’s development opens new avenues for research and treatment. Identifying specific molecules involved in this complex interplay could lead to the development of targeted therapies.

While completely shutting down estrogen production isn’t a viable solution, these insights offer hope for finding treatments that could mitigate the disease’s impact, especially for women, who are disproportionately affected by Alzheimer’s.

As we unravel the connections between our body’s hormonal balance, our gut health, and brain diseases like Alzheimer’s, we inch closer to finding effective treatments.

These studies not only deepen our understanding of the disease but also highlight the importance of personalized medicine in addressing complex health challenges.

If you care about Alzheimer’s, please read studies about Vitamin D deficiency linked to Alzheimer’s, vascular dementia, and Oral cannabis extract may help reduce Alzheimer’s symptoms.

For more information about brain health, please see recent studies about Vitamin B9 deficiency linked to higher dementia risk, and results showing flavonoid-rich foods could improve survival in Parkinson’s disease.

The research findings can be found in Molecular Neurodegeneration.

Copyright © 2024 Knowridge Science Report. All rights reserved.